Coyle Financial Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Buy
586
+104
+22% +$105K 0.11% 61
2025
Q4
$518K Buy
482
+189
+65% +$181K 0.11% 63
2025
Q3
$224K Buy
293
+10
+4% +$7.44K 0.05% 93
2025
Q2
$221K Buy
+283
New +$220K 0.06% 84
2018
Q3
Sell
-3,660
Closed -$312K 182
2018
Q2
$312K Buy
+3,660
New +$301K 0.29% 43

Other funds holding LLY

Coyle Financial Counsel's LLY Position: Q1 2026 in Review

Coyle Financial Counsel increased its Eli Lilly (LLY) stake by 22% in Q1 2026, buying an estimated $105K and bringing the position to 586 shares worth $539K. The position accounts for 0.11% of the portfolio, ranked #61.

Coyle Financial Counsel first reported a position in LLY in Q2 2018 and has held it in 5 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Coyle Financial Counsel held 586 shares of Eli Lilly worth $539K as of Q1 2026.
  • Coyle Financial Counsel bought 104 Eli Lilly shares in Q1 2026, an estimated $105K.
  • Eli Lilly made up 0.11% of Coyle Financial Counsel's portfolio in Q1 2026, its #61 holding.
  • Coyle Financial Counsel first reported a position in Eli Lilly in Q2 2018 and has held it in 5 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Coyle Financial Counsel's 13F filing for Q1 2026, filed 12 May 2026.